1 EDITION 2018 Topical Preparations Counselling Guide

1 Edition 2018 Topical Preparations Counselling Guide-PDF Download

  • Date:30 Dec 2019
  • Views:159
  • Downloads:7
  • Pages:49
  • Size:2.29 MB

Share Pdf : 1 Edition 2018 Topical Preparations Counselling Guide

Download and Preview : 1 Edition 2018 Topical Preparations Counselling Guide

Report CopyRight/DMCA Form For : 1 Edition 2018 Topical Preparations Counselling Guide


DISCLAIMER This guide would serve as a handy reference for PHARMACIST ONLY. and not as a complete drug information resource It is NOT intended to replicate or. replace the knowledge skills and experience of trained dermatologist health. professionals nor is it a substitute for clinical judgement and advice The nature of. healthcare drug information is that it is constantly evolving with ongoing research and. clinical experience and is often subject to interpretation While best effort has been. made to ensure the accuracy of the information and recommendation presented. reader is advised that the contributors editors reviewer and publisher cannot be. responsible for the continued updates of the information of any errors or and of any. consequences arising from its application,Pharmaceutical Services Programme. Ministry of Health Malaysia,Lot 36 Jalan Universiti. 46200 Petaling Jaya Selangor Malaysia,Tel 603 7841 3200 Fax 603 7968 2222. Website www pharmacy gov my,Dr Roshayati Mohamad Sani. Director of Pharmacy Practice and Development,Pharmaceutical Services Division.
Ministry of Health Malaysia,External Reviewer,Dr Rohana Ridzwan. Head of Department,Dermatology Department,Hospital Selayang. Editorial Committee,Mdm Noraini Mohamad,Deputy Director of Pharmaceutical Care. Pharmaceutical Services Division,Ministry of Health Malaysia. Ms Umi Kalthum binti Mohd Isa,Senior Assistant Director.
Pharmaceutical Services Division MOH,Contributors,Mdm Mazuin Mahmud Taridi. Senior Principal Assistant Director,Pharmaceutical Services Division MOH. Ms Low Nam Wei,Pharmacist Hospital Serdang,Ms Ng Hui Wen. Pharmacist Hospital Selayang,Ms Khairul Syazwani binti Mohd Arpan. Pharmacist Hospital Selayang,Mdm Noorul Huda binti Senawi.
Pharmacist Hospital Sultan Haji Ahmad Shah Temerloh. Ms Yap Cheng Hoon, Pharmacist Klinik Kesihatan Kepala Batas Pejabat Kesihatan Daerah Seberang Perai. Ms Roselyne John Han, Pharmacist Klinik Kesihatan Luyang PKK Kota Kinabalu. Ms Siti Syahirah Md Radzi,Pharmacist Hospital Tuanku Fauziah. FOREWORD BY, DIRECTOR OF PHARMACY PRACTICE AND DEVELOPMENT DIVISION. MINISTRY OF HEALTH MALAYSIA,Counselling is one of the important components in.
pharmaceutical care in which to ensure patients adhere to. their medication It is the responsibility of the pharmacists to. provide proper counseling and patient education in order to. achieve the best possible pharmacotherapy outcomes One of. the commonly counsel medication by the pharmacists is. topical preparations, Skin is known to be the largest organ of our body There are hundreds of skin. conditions that affect humans and it can vary greatly in symptoms and severity It can. be temporary or permanent and may be painless or painful Some may be caused by. external factors while others may be genetic Some skin conditions are minor and. easily treated and others can be life threatening, There are various types of treatment available in the Ministry of Health Malaysia. MOH Drug Formulary for treating skin conditions either orally or as topical treatment. This counselling guide provides information for pharmacists specifically on the topical. preparations available in the MOH formulary and relevant counselling points on its. usage in providing effective and accurate patient education regarding their medicines. I believe the contents of this quick guide will be helpful for pharmacists providing care. for patients in ensuring proper use of medications and for patients to be aware of. possible side effects, I would like to congratulate the Ambulatory Pharmacy Working Committee. Pharmaceutical Services Programme Ministry of Health for their efforts and. contributions to the development of this guideline. DR ROSHAYATI MOHAMAD SANI, DIRECTOR OF PHARMACY PRACTICE DEVELOPMENT DIVISION. MINISTRY OF HEALTH MALAYSIA,Introduction 1,A Body Anatomy 2.
B Terminology of skin condition 3,CHAPTER 1 INFECTIVE SKIN CONDITIONS 4. A Bacterial Skin Infections 4,i Impetigo Superficial Skin Infection 4. Topical preparation for treatment 4,2 Fucidic acid cream. 2 Mupirocin ointment,ii Cellulitis Deep Skin Infection 5. Topical preparation for treatment 5,Potassium Permanganate 5.
B Parasitic Skin Infections 7,i Scabies 7,Topical preparation for treatment 8. Emulsion Benzoyl Benzoate EBB,Permethrin 5 lotion,Crotamitone 10. 6 Sulphur ini Calamine Petrolatum,ii Head Lice 10,Topical preparation for treatment 10. Permethrin 1 lotion,Gamma Benzene Hexachloride GBH 0 1 lotion. C Fungal Skin Infections 12,i Dermatophyte infections Dermatophytoses 12.
Topical preparation for treatment, Topical Imidazole Miconazole cream powder Clotrimazole cream 14. ii Pityriasis Versicolor 15,Topical preparation for treatment 15. Selenium Sulphide 2 5 lotion or shampoo,Ketoconazole shampoo. Topical Imidazole Miconazole cream powder Clotrimazole cream. iii Cutaneous Candidiasis 16,Topical preparation for treatment 17. Topical Imidazole Miconazole cream powder Clotrimazole cream. Nystatin cream,Whitfield ointment,D Viral Skin Infections 19.
i Warts 19,Topical preparation for treatment 19,Salicylic acid 1 20. Podophyllum 10 20,Imiquimod 5 cream, CHAPTER 2 CHRONIC NON INFECTIVE SKIN CONDITIONS 21. A Eczema and Dermatitis 21,Topical preparation for treatment 22. Emollients,Aqueous cream,Emulsifying ointment,Liquid paraffin. Glycerin 25 50 in Aqueous cream,White Yellow soft paraffin.
Urea cream,Topical corticosteroids,Topical Calcineurin Inhibitors TCIS. Tacrolimus 0 03 0 1 ointment,Silver Nitrate 0 5 2 5 10 solution. B Psoriasis 28,Topical preparation for treatment 29. Topical corticosteroids,Tar based preparation,Vitamin D analogues. Dithranol Anthralin,CHAPTER 3 ACNE VULGARIS 32,Topical preparation for treatment 33.
Cetrimide 1 2 solution,Benzyl peroxide 5 10,Adapalene Tretinoin. Azelaic acid 20 cream,References 34, Appendix i Carta Alir Proses Kaunseling Produk Dermatologi Topikal 37. Appendix ii Rajah Pendispensan Ubat Dermatologi Topikal 38. Appendix iii General Counselling Points for Topical Dermatology Products 40. 1 INTRODUCTION, Skin is human s largest organ with a total area of about 2 square meters m2 covering. a human body It acts as a waterproof insulating shield that protects the body against. dehydration extremes temperature damaging sunlight and harmful chemicals Skin. also exudes an antibacterial substance that helps to prevent infection and. manufactures vitamin D for converting calcium into healthy bones6. Skin is made up of three layers, 1 Epidermis is the outermost layer of skin which provides a waterproof. barrier and creates our skin tone, 2 Dermis beneath the epidermis contains tough connective tissue hair.
follicles and sweat glands, 3 Subcutaneous tissue hypodermis is made of fat and connective tissue. Figure 1 Skin Anatomy,National Cancer Institute, Any damage clog or irritation to the skin layer or certain diseases immune. system problems can cause skin problems presented by symptoms of redness. itchiness burning and or swelling Nevertheless there are treatments available for. variety of skin conditions in the form of oral or topical preparation. This guide contains presentation of various skin conditions and its. management using topical preparations with few points to remember when giving. counselling It will be useful for pharmacist who conducts counselling on the use of. topical preparations available in Ministry of Health facilities. A Body Anatomy, Figure 2 Diagram of Human Body for Topical Application. Trunk Back Abdomen Chest,Anterior Hairline,Garis Rambut. Periobital,Lilitan Mata Neck,Perioral Leher,mulut Torso.
Forearm Abdomen Perut,Tapak Groin,Tangan Finger Webs Celah Peha. Celah Jari,Knee Perineal,Kering Toe Web,Celah Jari Kaki. Posterior Hairline,Garis Rambut Belakang,Gluteal Thigh. Punggung Peha Lower Limbs,Anggota bawah,Betis Kaki. B Table 1 Terminology of Skin Conditions,TERMINOLOGY DESCRIPTION.
Macule 1 cm diameter flat lesion with change of skin color. Atrophy Thin transparent epithelium or depression in the dermis. Lichenified Thickened skin with exaggerated skin crease. Sclerosis Indurated hardened skin, Targetoid Pink macule with central purplish papule. Annular Polycyclic pattern,Papule 0 5 cm diameter raised firm lesion. Vesicle 0 5 cm diameter raised firm lesion with clear fluid. Pustule 0 5 cm diameter raised firm lesion with yellow fluid. Plaque 1cm diameter raised flat top lesion,Nodule 0 5 cm diameter raised firm lesion. Bullae Blister 0 5 cm diameter raised fluid filled lesion. Desquamation Detachment of the superficial part of the skin. Excoriations Scratch Marks Shallow hemorrhagic excavation due to scratching. Necrosis Death of skin tissue,Erosions Partial loss of epithelium. Ulcer Full thickness loss of epithelium,Crust Dried exudates.
Blanchable Erythematous skin lesion appears pale on pressure. Non blanchable Skin lesion remain red purplish or pigmented on pressure. CHAPTER 1 INFECTIVE SKIN CONDITIONS,A Bacterial skin infection. i Impetigo Superficial Skin Infection, Impetigo is the most common skin infection in children It is caused mainly by. Staphylococcus aureus and sometimes by Streptococcus pyogenes group A Skin. signs include small blisters dark or honey colored crust that forms after the pustules. burst Immediate antibiotic treatment is advised for most cases of impetigo to achieve. a quick cure and prevent spread of the infection to other children. Figure 3 Presentation of Impetigo around the mouth area. National Health Institute,Treatment for Impetigo, For oral and IV antibiotic treatment please refer latest National Antibiotic. Guideline NAG,Topical preparations for Impetigo,a 2 Fusidic acid cream. MODE OF ACTION Antibacterial activity against Staphylococci. SIDE EFFECTS Contact Dermatitis, 1 application every 8 12 hour for duration of 7 days.
COUNSELLING POINTS Do not use for more than 2 weeks May use again if infection. b 2 Mupirocin ointment, Antibacterial activity against Staphylococcus aureus and. MODE OF ACTION,coagulase negative Staphyloocci,Common Burning. SIDE EFFECTS Uncommon Itchiness erythma stingging dryness. Uncommon Contact Dermatitis, 1 application every 8 12 hour for duration of 5 days. COUNSELLING POINTS Do not use for more than 2 weeks May use again if infection. ii Cellulitis Deep Skin Infection, Cellulitis is a bacterial infection of the deeper layers of the skin the dermis and the. subcutaneous tissue Cellulitis is most often caused by Streptococcus and. Staphylococcus aureus bacteria, These bacteria are able to cause an infection if they get into the skin through a break.
in the skin barrier This can happen with cuts scrapes ulcers macerated skin at toe. webs and surgical wounds Cellulitis may also develop in normal skin. The skin is usually painful red swollen warm and tender to touch It s often difficult. to identify the border between normal and infected skin. Figure 4 Bilateral leg cellulitis University of California. Treatment for Cellulitis, Cellulitis requires treatment with intravenous or oral antibiotics Refer to latest. National Antibiotic Guideline NAG for treatment, Topical preparation potassium permanganate solution is used to dry up lesions. and blisters,Potassium Permanganate 5, Mild antiseptic and astringent properties which reduce the foul smell. MECHANISM OF ACTION,from infected wound,Can cause staining on clothing skin and nail. It may cause a stinging sensation in some people,SIDE EFFECTS.
If it is too concentrated it may cause severe dry skin and fissure. To be use diluted as Figure 5 below,f e d c b a,a b Too diluted ineffective. e f Too concentrated cause side effects, Figure 5 Potassium Permanganate at different dilution. COUNSELLING POINTS, Dilute 2 drops 0 1 ml in 50 ml of normal saline water to make. 1 10 000 Picture 5d, Dilute 2 drops 0 1ml in 100 ml of normal saline water to make. 1 20 000 Picture 5c, Use as wash use as final rinse dab wet wrap for 20 minutes.
until there is no weeping lesions, Use immediately after diluting Solution that are left standing can. turn brown oxidized and is ineffective, Advise patient to stop using this solution once skin become dry to. avoid fissuring of skin,B Parasitic skin infection. A highly pruritic and contagious parasitic disease caused by Sarcoptes scabies. Associated with poverty and overcrowded area nursing home prisons and hospital. wards Scabies can be transmitted through a direct skin to skin contact with an. infected person,Figure 6 Presentation of scabies MedicineNet com. Sign and symptom of scabies are not difficult to detect patient will experience severe. itchiness during night time and when sweating Possible part of body affected by. scabies are wrist toes finger webs arm buttock breast nipple waist line genitalia. as shown in Figure 7, Figure 7 Common body area affected with scabies in red.
Allstop com,Treatment for Scabies, Immediate treatment for the patient treat secondary infection first as most. scabicides are irritant, Treatment of patient and any household contacts who may or may not b. variety of skin conditions in the form of oral or topical preparation This guide contains presentation of various skin conditions and its management using topical preparations with few points to remember when giving counselling It will be useful for pharmacist who conducts counselling on the use of topical preparations available in Ministry of Health facilities Figure 1 Skin Anatomy

Related Books